However, after further adjustment for the other cardiovascular risk factors, CVD and albuminuria, only MMP-2 [0.36 (0.06; 0.66)] remained significantly higher in patients with proliferative retinopathy vs. those without retinopathy (Figure 2B; Additional file 3: Table S3, Model 2). This evidence concerns the gene MMP2 and retinal disorder.